Medical Oncology
肿瘤内科 · Beijing Shijitan Hospital, Beijing
The Department of Medical Oncology provides comprehensive cancer care by combining translational research with clinical practice. The department emphasizes individualized treatment and introduced the concept of stratified therapy targeting specific metastatic sites. It maintains academic collaborations with institutions including Duke University, Harvard University, the US National Institutes of Health (NIH), and the University of Tokyo. H. Kim Lyerly from Duke University serves as co-director of the affiliated Cancer Center. The department operates two wards: one for breast, lung, and gastrointestinal cancers, and another specializing in gliomas and brain metastases. This approach aligns with international standards for integrated tumor management.
Conditions and treatments
- Treatment for breast cancer
- Treatment for lung cancer
- Treatment for gastrointestinal tumors
- Comprehensive care for gliomas
- Treatment for brain metastases
- Individualized stratified therapy for metastasis
Key facts
- Ward 1 has 43 beds.
- Ward 2 has 12 beds.
- The department operates two inpatient wards.
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Specialty | Medical Oncology |
|---|---|
| Doctors listed | 12 |
| Chief physicians | 4 |
Senior doctors
Chief and associate chief physicians listed for this department on public doctor-listing platforms (2025–2026).
Chief physicians
- Jianxin Chen陈建新
- Lei Zhou周蕾
- Hongyan Huang黄红艳
- Yanjie Zhao赵艳杰
Associate chief physicians
- Yan Di邸岩
- Ni Jiang姜妮
- Yan Li李岩
- Shan Li李珊 · Lecturer
- Jing Zhao赵静
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us